For the year ending 2025-12-31, STRO has $173,830K in assets. $306,282K in debts. $58,130K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 58,130 | |||
| Marketable securities | 83,298 | |||
| Accounts receivable | 3,977 | |||
| Prepaid expenses and other current assets | 5,521 | |||
| Total current assets | 150,926 | |||
| Total | 38,000 | |||
| Less accumulated depreciation and amortization | 27,352 | |||
| Property and equipment, net | 10,648 | |||
| Operating lease right-of-use assets | 10,903 | |||
| Other non-current assets | 495 | |||
| Restricted cash | 858 | |||
| Total assets | 173,830 | |||
| Accounts payable | 7,565 | |||
| Accrued compensation | 14,642 | |||
| Deferred revenue-current | 10,562 | |||
| Operating lease liability - current | 7,783 | |||
| Accrued expenses and other current liabilities | 34,581 | |||
| Total current liabilities | 75,133 | |||
| Deferred revenue, non-current | 2,028 | |||
| Operating lease liability - non-current | 7,891 | |||
| Deferred royalty obligation related to the sale of future royalties | 219,536 | |||
| Other non-current liabilities | 1,694 | |||
| Total liabilities | 306,282 | |||
| Common stock, 0.001 par value - 300,000,000 shares authorized as of december 31, 2025 and december 31, 2024 8,584,309 and 8,306,398 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively | 9 | |||
| Additional paid-in-capital | 845,475 | |||
| Accumulated other comprehensive income | 19 | |||
| Accumulated deficit | -977,955 | |||
| Total stockholders' equity (deficit) | -132,452 | |||
| Total liabilities and stockholders' equity (deficit) | 173,830 | |||
SUTRO BIOPHARMA, INC. (STRO)
SUTRO BIOPHARMA, INC. (STRO)